histone H2AXY142 kinase activity GO:0140801

GO:0140801, histone H2AXY142 kinase activity, is a molecular function term that captures the enzymatic addition of a phosphate group to histone variant H2AX at tyrosine 142. Histone H2AX is a specialized histone that becomes phosphorylated in response to DNA double-strand breaks and replication stress, and this phosphorylation is widely used as a marker of DNA damage signalling. The kinase activity defined by GO:0140801 is therefore a key upstream event that converts a chromatin substrate into a signalling platform for repair, checkpoint, and transcriptional responses. For researchers, this term provides a precise ontology handle for annotating kinases, designing phospho-specific assays, and interpreting chromatin modification data in normal and diseased cells. Because H2AX phosphorylation influences stem cell radioresponses, the activity is relevant to both regenerative biology and cancer therapy. Understanding GO:0140801 helps connect molecular enzymology to cellular outcomes such as radiosensitivity, genome stability, and stem cell maintenance.

In simple terms, GO:0140801 describes the reaction in which a kinase enzyme transfers a phosphate group from ATP onto the amino acid tyrosine at position 142 of histone H2AX. The QuickGO definition states that this is the catalysis of the reaction: histone H2AX-tyrosine (position 142) + ATP = histone H2AX-phosphotyrosine (position 142) + ADP. Although the definition text mentions a serine residue in one sentence, the official term name and synonyms specify tyrosine 142, and the reaction is the addition of a phosphate group to H2AX at that position. The activity is synonymous with gamma-H2AX-S142 kinase activity, histone H2AX-Y142 kinase activity, histone H2AY142 kinase activity, and histone kinase activity (H2AX-Y142 specific). This molecular function is a chromatin-modifying enzymatic activity that generates a phospho-histone mark used in DNA damage and stem cell biology.

GO:0140801 is important because it defines the enzymatic step that generates a major chromatin mark used to detect and respond to DNA damage. This activity influences how normal stem cells react to radiation, which has direct implications for radiotherapy, tissue regeneration, and cancer predisposition. By annotating kinases with this term, researchers can systematically compare enzymes that modify H2AX and dissect their contributions to genome stability. The activity also provides a mechanistic link between ATP-dependent signalling and chromatin architecture, making it relevant to epigenetics, cancer biology, and stem cell research.

The following genes and proteins are functionally connected to histone H2AXY142 kinase activity, either as the histone substrate, modifying enzymes, or downstream effectors.

The activity defined by GO:0140801 is regulated at multiple levels, including kinase recruitment to chromatin, cell cycle phase, and the balance between phosphorylation and dephosphorylation. DNA damage and replication stress stimulate the activity, while phosphatases such as PP2A and WIP1 remove the phosphate mark to reset signalling. In normal stem cells, the interplay between H2AX phosphorylation and H3K56 acetylation modulates radioresponses, indicating that chromatin context and other histone modifications regulate the outcome of this activity.

Altered H2AX phosphorylation is associated with genome instability and altered radiosensitivity in cancer cells. Because GO:0140801 generates a key DNA damage mark, its dysregulation can contribute to tumorigenesis and influence responses to radiotherapy. Studying this activity helps identify vulnerabilities in cancers with defective DNA damage signalling.

H2AX phosphorylation and H3K56 acetylation uniquely influence normal stem cell radioresponses, linking GO:0140801 to tissue regeneration and aging. Defects in this pathway may impair stem cell maintenance and recovery after genotoxic stress. This has implications for regenerative medicine and for understanding radiation injury.

Persistent DNA damage and defective H2AX signalling have been linked to neuronal dysfunction and aging-related phenotypes. Although direct evidence for GO:0140801 in neurodegeneration is limited, the activity is part of the broader DNA damage response that protects post-mitotic cells. Model systems with altered H2AX phosphorylation can help test this connection.

Phospho-specific antibodies against gamma-H2AX are widely used to detect the product of GO:0140801 activity in cells and tissues. Immunofluorescence foci analysis allows quantification of H2AX phosphorylation at the single-cell level after DNA damage. These methods are standard for assessing radioresponses in stem and cancer cells.

Mass spectrometry can identify and quantify phosphorylation of H2AX at specific residues, including Y142. Proteomic approaches enable unbiased mapping of phosphorylation sites and their dynamics after genotoxic stress. These methods help validate kinase-substrate relationships for GO:0140801.

ChIP-seq using phospho-H2AX antibodies maps the genomic distribution of this mark. This reveals how H2AX phosphorylation relates to chromatin state and transcription. Combining ChIP with other histone modification assays helps dissect crosstalk such as H3K56 acetylation.

CRISPR knockout and activation screens can identify genes that regulate H2AX phosphorylation. These screens link candidate kinases and phosphatases to the activity defined by GO:0140801. Functional validation follows with targeted assays and phenotypic readouts.

Researchers studying histone H2AXY142 kinase activity-related genes often need to determine whether a candidate gene is causally involved in H2AX phosphorylation, DNA damage signalling, or stem cell radioresponses. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations and functional readouts for this purpose.

GO:0140801, histone H2AXY142 kinase activity, defines a chromatin-modifying enzymatic reaction that generates a critical phospho-histone mark. This activity is central to DNA damage signalling, stem cell radioresponses, and genome stability, making it a valuable target for cancer and regenerative biology research. By combining precise CRISPR models with phospho-specific and genomic assays, researchers can dissect the regulators and consequences of this activity in health and disease.